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OBJECTIVE — Pressure mitigation is crucial for the healing of plantar diabetic foot ulcers.
We therefore discuss characteristics and considerations associated with the use of ofﬂoading
devices.
RESEARCH DESIGN AND METHODS — A diabetic foot ulcer management survey
was sent to foot clinics in all 50 states and the District of Columbia in 2005. A total of 901
geographically diverse centers responded. The survey recorded information regarding usage
frequency and characteristics of assessment and treatment of diabetic foot ulcers in each center.
RESULTS — Of the 895 respondents who treat diabetic foot ulcers, shoe modiﬁcations
(41.2%, P  0.03) were the most common form of pressure mitigation, whereas total contact
casts were used by only 1.7% of the centers.
CONCLUSIONS — This study reports the usage and characteristics of ofﬂoading devices in
the care of diabetic foot ulcers in a broadly distributed geographic sample. Less than 2% of
specialists use what has been termed the “gold standard” (total contact cast) for treating the
majority of diabetic foot ulcers.
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I
n the treatment of diabetic foot ulcers,
pressure modulation, commonly re-
ferred to as “ofﬂoading,” is most suc-
cessful when pressure is mitigated at an
area of high vertical or shear stress (1).
Common methods to ofﬂoad the foot in-
clude bed rest, wheel chair, crutch-
assisted gait, total contact casts, felted
foam, half shoes, therapeutic shoes, and
removable cast walkers (2). Although it is
well known that pressure mitigation
through ofﬂoading devices is crucial for
the healing of plantar diabetic foot ulcers,
thereare,tothebestofourknowledge,no
reports in the literature that describe the
characteristics and considerations associ-
ated with the use of pressure mitigation
devices in a broad geographically diverse
sample of specialists. Therefore, the pur-
pose of this study was to describe the
characteristics and considerations associ-
ated with the use of ofﬂoading devices in
foot clinics in the U.S.
RESEARCH DESIGN AND
METHODS— A diabetic foot man-
agement survey was sent to 5,200 private
and academic practices and clinics in all
50 states and the District of Columbia in
2005. A total of 901 geographically di-
verse centers responded from 48 states
and the District of Columbia. The data
were analyzed by dividing the U.S. into
four census regions (West, Midwest,
South, and Northeast) based on regions
describedbytheU.S.CensusBureau.The
survey recorded information about the
usage frequency and characteristics of as-
sessment and treatment of diabetic foot
ulcers in each center.
RESULTS— Of the 901 respondents,
895 centers actively treated diabetic foot
ulcers. The type and frequency of plantar
ofﬂoading used is summarized in Figure
1. Of the 895 centers, shoe modiﬁcations
(41.2%, P  0.03) were the most com-
mon form of pressure mitigation in
51% of diabetic foot ulcer treatments.
There were no signiﬁcant regional differ-
ences in therapy. Total contact casts
(TCCs) were used by only 1.7% of the
centers for the majority of diabetic foot
ulcer treatment, whereas 15.2% of the
centers reported use of removable cast
walkers. A total of 2.6% of the centers
reported application of other modalities
such as therapeutic shoes, and 12.3% of
thecentersreporteduseofcompletenon–
weight-bearing (NWB) strategies such as
crutches and wheelchairs for the majority
of treatment. A total of 58.1% (520 cen-
ters) did not consider TCCs as the gold
standard to ofﬂoad the noninfected plan-
tardiabeticfootulcers.Atotalof45.5%of
the centers nationwide reported no use of
TCCs as an ofﬂoading modality. Com-
monly reported factors affecting fre-
quency of TCC usage included patient
tolerance (55.3%), the time needed to ap-
ply the cast (54.3%), cost of materials
(31.6%), reimbursement issues (27.5%),
familiarity with method of application
(25%), customizing parts (20.9%), staff-
ing/ordering supplies (15.2%), and clini-
cian coverage (10.6%).
CONCLUSIONS — TCCs have been
consideredthegoldstandardbyacademi-
ciansandconsensuscommitteesalike(3);
however, the results of this study suggest
that this standard is actively used by
merely 1.7% of centers for treatment of
the majority of plantar diabetic foot ulcer
treatment. Most of the centers (73.4%)
used TCCs in 25% of their patients, but
(at best) intermittently. A further 45.5%
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and clinical reality may be secondary to a
number of potential negative attributes
that may discourage clinicians from using
this modality. TCC application is time-
consuming and often associated with a
learningcurve.Mostcentersdonothavea
physicianorcasttechnicianavailablewith
adequate training or experience to safely
apply a TCC. Moreover, TCCs do not al-
low patients, family members, or health
careproviderstoassessthefootorwound
on a daily basis and are therefore often
contraindicated in cases of soft tissue in-
fections or osteomyelitis. Other patient
complaints may include impaired activi-
tiesofdailyliving,suchasdifﬁcultysleep-
ing comfortably, and bathing difﬁculties
while trying to avoid getting the cast wet.
Certain designs of TCCs may also exacer-
bate postural instability (4).
Removable cast walkers (RCW) are,
as their name implies, cast-like devices
that are removable to allow for self-
inspection of the wound and application
of topical therapies that require frequent
administration. Further, RCWs can be
easily converted into an instant TCC
(iTCC) (5). Wound healing efﬁcacy and
cost-effectiveness of iTCCs have been
demonstratedinseveralrandomizedcon-
trolledtrials(6,7).However,theresultsof
this survey suggested that RCWs were
only used by 15.2% of the centers in the
treatment of the majority of the wounds
treated. Almost half of the centers (48%)
used RCWs in 25% of plantar diabetic
foot ulcers. The most likely explanation is
the cost and lack of reimbursement asso-
ciated with RCWs in the U.S. Most pa-
tients either cannot or are not willing to
paytheextramoneyfortheRCW,forcing
clinicians to absorb the extra cost.
Whereas no ofﬂoading modality was
used 100% of the time by the centers as-
sessed, shoe modiﬁcation was by far the
mostcommonlyused.Thisisdespitedata
thatsuggeststhesearenoteffectivemeans
of ofﬂoading (8). Additionally, there are
real concerns that an aperture applied
around the wound based solely on visual
cues may increase shear and vertical
forces at the wound’s periphery second-
arytothe“edgeeffect”(9).Thepopularity
of shoe modiﬁcations may be secondary
to many factors. Patients are often resis-
tant to cast applications or the extra costs
associated with RCWs. Clinicians are
therefore compelled to use alternative
methods such as shoe modiﬁcations that
are less costly and reimbursable. Further,
patients are often more tolerant of the
slight modiﬁcations made to shoes with
which they are familiar.
We are unaware of other reports in
the medical literature that have reported
usage frequency and characteristics of of-
ﬂoading devices in the podiatric medical
care of diabetic foot ulcers. Fewer than
2% of centers use what has been termed
the gold standard (TCCs) for treating the
majority of diabetic foot ulcers in this
broadly distributed sample. Based on
these ﬁndings, it is likely that although
most specialists understand that amelio-
ration of pressure, shear, and repetitive
injury are principal tenets of diabetic foot
ulcer care, the cost/beneﬁt analysis, reali-
ties of maintaining a busy clinical prac-
tice, the available manpower, and
reimbursement issues may inﬂuence cli-
nicians to use less optimal pressure miti-
gation methods.
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Figure 1—Type and frequency of plantar ofﬂoading used across 895 clinics.
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